Tessari Eben, Chief Operating Officer at Kiniksa Pharmaceuticals International ($KNSA), sold about $16.6 million in company shares across 24 open market transactions over the past year. The most recent sale occurred on December 15, 2025. These sales rank 776th among 11,678 individual insiders in our database, outpacing the average of $8.6 million per insider and 6.4 transactions. Eben made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF STRATEGY OFFICER | M | Restricted Share Unit | 1745 | $0.00 | 3,490.0000 | 78,979,030 | 33.33% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF STRATEGY OFFICER | F | Class A Ordinary Share | 1756 | $48.13 | 21,250.0000 | 78,979,030 | 7.63% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF STRATEGY OFFICER | A | Share Option | 33200 | $0.00 | 33,200.0000 | 78,979,030 | 9999.99% | 0.04% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF STRATEGY OFFICER | A | Restricted Share Unit | 8300 | $0.00 | 8,300.0000 | 78,979,030 | 9999.99% | 0.01% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF STRATEGY OFFICER | A | Performance Share Unit | 16600 | $0.00 | 16,600.0000 | 78,979,030 | 9999.99% | 0.02% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF STRATEGY OFFICER | M | Restricted Share Unit | 1773 | $0.00 | 1,772.0000 | 78,979,030 | 50.01% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF STRATEGY OFFICER | M | Restricted Share Unit | 2457 | $0.00 | 7,371.0000 | 78,979,030 | 25.00% | 0.00% |
| Jan. 15, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF STRATEGY OFFICER | A | Class A Ordinary Share | 365 | $24.16 | 17,031.0000 | 78,979,030 | 2.19% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF STRATEGY OFFICER | M | Class A Ordinary Share | 5975 | $0.00 | 23,006.0000 | 78,979,030 | 35.08% | 0.01% |
| Dec. 15, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 6000 | $8.83 | 28,714.0000 | 80,035,400 | 26.42% | 0.01% |
| Dec. 15, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 12048 | $41.56 | 16,666.0000 | 80,035,400 | 41.96% | 0.02% |
| Dec. 15, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 6000 | $0.00 | 0.0000 | 80,035,400 | 100.00% | 0.01% |
| Nov. 26, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 200 | $22.89 | 22,914.0000 | 80,035,400 | 0.88% | 0.00% |
| Nov. 26, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 200 | $42.89 | 22,714.0000 | 80,035,400 | 0.87% | 0.00% |
| Nov. 26, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 200 | $0.00 | 46,938.0000 | 80,035,400 | 0.42% | 0.00% |
| Nov. 17, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 6500 | $0.00 | 6,000.0000 | 80,035,400 | 52.00% | 0.01% |
| Nov. 17, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 6500 | $8.83 | 35,184.0000 | 80,035,400 | 22.66% | 0.01% |
| Nov. 17, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 645 | $40.08 | 34,539.0000 | 80,035,400 | 1.83% | 0.00% |
| Nov. 17, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 11825 | $41.30 | 22,714.0000 | 80,035,400 | 34.24% | 0.01% |
| Oct. 14, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 6500 | $0.00 | 12,500.0000 | 80,035,400 | 34.21% | 0.01% |
| Oct. 14, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 6500 | $8.83 | 41,052.0000 | 80,035,400 | 18.81% | 0.01% |
| Oct. 14, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 11815 | $37.65 | 29,237.0000 | 80,035,400 | 28.78% | 0.01% |
| Oct. 14, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 553 | $37.99 | 28,684.0000 | 80,035,400 | 1.89% | 0.00% |
| Sept. 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 42000 | $38.33 | 34,552.0000 | 77,942,082 | 54.86% | 0.05% |
| Sept. 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 42000 | $0.00 | 0.0000 | 77,942,082 | 100.00% | 0.05% |
| Sept. 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 42000 | $17.92 | 76,552.0000 | 77,942,082 | 121.56% | 0.05% |
| Sept. 15, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 16044 | $36.45 | 34,908.0000 | 77,942,082 | 31.49% | 0.02% |
| Sept. 15, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 6500 | $0.00 | 19,000.0000 | 77,942,082 | 25.49% | 0.01% |
| Sept. 15, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 6500 | $8.83 | 50,952.0000 | 77,942,082 | 14.62% | 0.01% |
| Sept. 15, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 356 | $37.00 | 34,552.0000 | 77,942,082 | 1.02% | 0.00% |
| Sept. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 38725 | $15.50 | 83,177.0000 | 77,942,082 | 87.12% | 0.05% |
| Sept. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 46546 | $15.52 | 129,723.0000 | 77,942,082 | 55.96% | 0.06% |
| Sept. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 85271 | $35.52 | 44,452.0000 | 77,942,082 | 65.73% | 0.11% |
| Sept. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 13389 | $0.00 | 0.0000 | 77,942,082 | 100.00% | 0.02% |
| Sept. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 46546 | $0.00 | 13,389.0000 | 77,942,082 | 77.66% | 0.06% |
| Sept. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 38725 | $0.00 | 6,249.0000 | 77,942,082 | 86.11% | 0.05% |
| Sept. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 13389 | $35.66 | 44,452.0000 | 77,942,082 | 23.15% | 0.02% |
| Sept. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 13389 | $15.52 | 57,841.0000 | 77,942,082 | 30.12% | 0.02% |
| Sept. 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 1964 | $0.00 | 45,402.0000 | 77,942,082 | 4.52% | 0.00% |
| Sept. 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 15026 | $0.00 | 44,974.0000 | 77,942,082 | 25.04% | 0.02% |
| Sept. 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 65 | $0.00 | 59,935.0000 | 77,942,082 | 0.11% | 0.00% |
| Sept. 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 1964 | $0.00 | 0.0000 | 77,942,082 | 100.00% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 2726 | $0.00 | 2,726.0000 | 77,942,082 | 50.00% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 1773 | $0.00 | 3,545.0000 | 77,942,082 | 33.34% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 1746 | $0.00 | 5,235.0000 | 77,942,082 | 50.04% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Share Option | 39364 | $0.00 | 39,364.0000 | 77,942,082 | 9999.99% | 0.05% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Restricted Share Unit | 9828 | $0.00 | 9,828.0000 | 77,942,082 | 9999.99% | 0.01% |
| Sept. 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 15091 | $35.50 | 44,452.0000 | 77,942,082 | 25.34% | 0.02% |
| Sept. 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 15026 | $15.50 | 59,543.0000 | 77,942,082 | 33.75% | 0.02% |
| Sept. 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 65 | $15.52 | 44,517.0000 | 77,942,082 | 0.15% | 0.00% |
| Sept. 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Ordinary Share | 950 | $34.28 | 44,452.0000 | 77,942,082 | 2.09% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Ordinary Share | 3022 | $33.49 | 43,438.0000 | 77,942,082 | 6.50% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 2726 | $0.00 | 46,460.0000 | 77,942,082 | 6.23% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 1773 | $0.00 | 43,734.0000 | 77,942,082 | 4.23% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 1746 | $0.00 | 41,961.0000 | 77,942,082 | 4.34% | 0.00% |
| Aug. 18, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 6500 | $8.83 | 56,415.0000 | 77,942,082 | 13.02% | 0.01% |
| Aug. 18, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 100 | $34.44 | 40,215.0000 | 77,942,082 | 0.25% | 0.00% |
| Aug. 18, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 16100 | $33.77 | 40,315.0000 | 77,942,082 | 28.54% | 0.02% |
| Aug. 18, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 6500 | $0.00 | 25,500.0000 | 77,942,082 | 20.31% | 0.01% |
| Aug. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 30444 | $12.97 | 119,287.0000 | 77,942,082 | 34.27% | 0.04% |
| July 15, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Class A Ordinary Share | 752 | $15.63 | 49,915.0000 | 77,942,082 | 1.53% | 0.00% |
| Aug. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 32710 | $11.10 | 151,997.0000 | 77,942,082 | 27.42% | 0.04% |
| Aug. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 10636 | $10.76 | 188,529.0000 | 77,942,082 | 5.98% | 0.01% |
| Aug. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 25896 | $11.97 | 177,893.0000 | 77,942,082 | 17.04% | 0.03% |
| Aug. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 38928 | $10.36 | 88,843.0000 | 77,942,082 | 77.99% | 0.05% |
| Aug. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 10636 | $0.00 | 31,908.0000 | 77,942,082 | 25.00% | 0.01% |
| Aug. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 25896 | $0.00 | 39,524.0000 | 77,942,082 | 39.58% | 0.03% |
| Aug. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 32710 | $0.00 | 32,710.0000 | 77,942,082 | 50.00% | 0.04% |
| Aug. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 30444 | $0.00 | 16,694.0000 | 77,942,082 | 64.58% | 0.04% |
| Aug. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 38928 | $0.00 | 0.0000 | 77,942,082 | 100.00% | 0.05% |
| Aug. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 550 | $33.90 | 49,915.0000 | 77,942,082 | 1.09% | 0.00% |
| Aug. 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 138064 | $33.20 | 50,465.0000 | 77,942,082 | 73.23% | 0.18% |
| July 14, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 6500 | $0.00 | 32,000.0000 | 77,942,082 | 16.88% | 0.01% |
| July 14, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 18900 | $28.72 | 49,163.0000 | 77,942,082 | 27.77% | 0.02% |
| July 14, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 6500 | $8.83 | 68,063.0000 | 77,942,082 | 10.56% | 0.01% |
| June 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 6500 | $0.00 | 38,500.0000 | 76,145,617 | 14.44% | 0.01% |
| June 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 6500 | $8.83 | 78,863.0000 | 76,145,617 | 8.98% | 0.01% |
| June 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 17300 | $28.28 | 61,563.0000 | 76,145,617 | 21.94% | 0.02% |
| June 11, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 45042 | $0.00 | 38,928.0000 | 76,145,617 | 53.64% | 0.06% |
| June 9, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 10319 | $10.36 | 82,682.0000 | 76,145,617 | 14.26% | 0.01% |
| June 9, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 10319 | $30.38 | 72,363.0000 | 76,145,617 | 12.48% | 0.01% |
| June 10, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 15506 | $10.36 | 87,869.0000 | 76,145,617 | 21.43% | 0.02% |
| June 10, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 15506 | $30.46 | 72,363.0000 | 76,145,617 | 17.65% | 0.02% |
| June 11, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 45042 | $10.36 | 117,405.0000 | 76,145,617 | 62.24% | 0.06% |
| June 11, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 45042 | $30.51 | 72,363.0000 | 76,145,617 | 38.36% | 0.06% |
| June 9, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 10319 | $0.00 | 99,476.0000 | 76,145,617 | 9.40% | 0.01% |
| June 10, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 15506 | $0.00 | 83,970.0000 | 76,145,617 | 15.59% | 0.02% |
| May 19, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 12000 | $26.41 | 72,363.0000 | 76,145,617 | 14.22% | 0.02% |
| May 19, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 7000 | $3.80 | 84,363.0000 | 76,145,617 | 9.05% | 0.01% |
| May 19, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 7000 | $0.00 | 49.0000 | 76,145,617 | 99.30% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Performance Share Option | 8042 | $0.00 | 8,042.0000 | 76,145,617 | 9999.99% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Performance Share Unit | 4975 | $0.00 | 4,975.0000 | 76,145,617 | 9999.99% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Performance Share Unit | 5224 | $0.00 | 5,224.0000 | 76,145,617 | 9999.99% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Performance Share Option | 8302 | $0.00 | 8,302.0000 | 76,145,617 | 9999.99% | 0.01% |
| April 14, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 6421 | $20.74 | 77,363.0000 | 76,145,617 | 7.66% | 0.01% |
| April 14, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 7000 | $3.80 | 89,363.0000 | 76,145,617 | 8.50% | 0.01% |
| April 14, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 5579 | $20.19 | 83,784.0000 | 76,145,617 | 6.24% | 0.01% |
| April 14, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 7000 | $0.00 | 7,049.0000 | 76,145,617 | 49.83% | 0.01% |
| April 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Ordinary Share | 801 | $20.28 | 82,363.0000 | 76,145,617 | 0.96% | 0.00% |
| April 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 2726 | $0.00 | 83,164.0000 | 76,145,617 | 3.39% | 0.00% |
| April 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 2726 | $0.00 | 2,726.0000 | 76,145,617 | 50.00% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 1773 | $0.00 | 3,545.0000 | 76,145,617 | 33.34% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 1746 | $0.00 | 5,235.0000 | 76,145,617 | 25.01% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Performance Share Unit | 19657 | $0.00 | 19,657.0000 | 76,145,617 | 9999.99% | 0.03% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Restricted Share Unit | 9828 | $0.00 | 9,828.0000 | 76,145,617 | 9999.99% | 0.01% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Share Option | 39364 | $0.00 | 39,364.0000 | 76,145,617 | 9999.99% | 0.05% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Ordinary Share | 513 | $21.77 | 80,438.0000 | 76,145,617 | 0.63% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Ordinary Share | 521 | $21.77 | 80,951.0000 | 76,145,617 | 0.64% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 1746 | $0.00 | 81,472.0000 | 76,145,617 | 2.19% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 1773 | $0.00 | 79,726.0000 | 76,145,617 | 2.27% | 0.00% |
| March 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 1964 | $0.00 | 78,530.0000 | 71,424,159 | 2.57% | 0.00% |
| March 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Ordinary Share | 577 | $22.61 | 77,953.0000 | 71,424,159 | 0.73% | 0.00% |
| March 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 1964 | $0.00 | 0.0000 | 71,424,159 | 100.00% | 0.00% |
| March 10, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 7000 | $0.00 | 14,049.0000 | 71,424,159 | 33.26% | 0.01% |
| March 10, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 7000 | $3.80 | 88,975.0000 | 71,424,159 | 8.54% | 0.01% |
| March 10, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 12409 | $21.06 | 76,566.0000 | 71,424,159 | 13.95% | 0.02% |
| Feb. 10, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 7000 | $0.00 | 21,049.0000 | 71,424,159 | 24.96% | 0.01% |
| Feb. 10, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 7000 | $3.80 | 95,975.0000 | 71,424,159 | 7.87% | 0.01% |
| Feb. 10, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 14000 | $19.57 | 81,975.0000 | 71,424,159 | 14.59% | 0.02% |
| Jan. 13, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 7000 | $3.80 | 102,975.0000 | 71,424,159 | 7.29% | 0.01% |
| Jan. 13, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 7000 | $0.00 | 28,049.0000 | 71,424,159 | 19.97% | 0.01% |
| Jan. 13, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 1677 | $19.08 | 88,975.0000 | 71,424,159 | 1.85% | 0.00% |
| Jan. 13, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 12323 | $18.13 | 90,652.0000 | 71,424,159 | 11.97% | 0.02% |
| Dec. 16, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 23017 | $20.44 | 95,975.0000 | 71,726,685 | 19.34% | 0.03% |
| Dec. 16, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 16017 | $1.59 | 118,992.0000 | 71,726,685 | 15.55% | 0.02% |
| Dec. 16, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 16017 | $0.00 | 0.0000 | 71,726,685 | 100.00% | 0.02% |
| Nov. 18, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 10000 | $0.00 | 16,017.0000 | 71,726,685 | 38.44% | 0.01% |
| Nov. 18, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 17000 | $21.04 | 102,975.0000 | 71,726,685 | 14.17% | 0.02% |
| Nov. 18, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 10000 | $1.59 | 119,975.0000 | 71,726,685 | 9.09% | 0.01% |
| Oct. 15, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 10000 | $0.00 | 26,017.0000 | 71,726,685 | 27.76% | 0.01% |
| Oct. 15, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 10000 | $1.59 | 126,975.0000 | 71,726,685 | 8.55% | 0.01% |
| Oct. 15, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 17000 | $26.87 | 109,975.0000 | 71,726,685 | 13.39% | 0.02% |
| Sept. 23, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 17500 | $24.99 | 116,975.0000 | 71,004,640 | 13.01% | 0.02% |
| Sept. 23, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 10000 | $1.59 | 134,475.0000 | 71,004,640 | 8.03% | 0.01% |
| Sept. 23, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 10000 | $0.00 | 36,017.0000 | 71,004,640 | 21.73% | 0.01% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 1773 | $0.00 | 5,318.0000 | 71,004,640 | 25.00% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 2726 | $0.00 | 5,452.0000 | 71,004,640 | 33.33% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Share Option | 36300 | $0.00 | 36,300.0000 | 71,004,640 | 9999.99% | 0.05% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Restricted Share Unit | 6981 | $0.00 | 6,981.0000 | 71,004,640 | 9999.99% | 0.01% |
| Sept. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Ordinary Share | 577 | $26.74 | 124,475.0000 | 71,004,640 | 0.46% | 0.00% |
| Sept. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 1964 | $0.00 | 125,052.0000 | 71,004,640 | 1.60% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Ordinary Share | 1322 | $26.74 | 123,088.0000 | 71,004,640 | 1.06% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 4499 | $0.00 | 124,410.0000 | 71,004,640 | 3.75% | 0.01% |
| Sept. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 1964 | $0.00 | 1,964.0000 | 71,004,640 | 50.00% | 0.00% |
| Aug. 27, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 10000 | $0.00 | 46,017.0000 | 71,004,640 | 17.85% | 0.01% |
| Aug. 27, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Ordinary Share | 17500 | $26.91 | 119,911.0000 | 71,004,640 | 12.74% | 0.02% |
| Aug. 27, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 10000 | $1.59 | 137,411.0000 | 71,004,640 | 7.85% | 0.01% |
| April 8, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Common Share | 801 | $17.90 | 126,024.0000 | 70,633,023 | 0.63% | 0.00% |
| April 8, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Common Share | 2726 | $0.00 | 126,825.0000 | 70,633,023 | 2.20% | 0.00% |
| April 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Share Option | 36300 | $0.00 | 36,300.0000 | 70,633,023 | 9999.99% | 0.05% |
| April 8, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 2726 | $0.00 | 9,573.0000 | 70,633,023 | 22.16% | 0.00% |
| April 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Restricted Share Unit | 6981 | $0.00 | 12,299.0000 | 70,633,023 | 131.27% | 0.01% |
| April 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Performance Share Unit | 5585 | $0.00 | 5,585.0000 | 70,633,023 | 9999.99% | 0.01% |
| April 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 1773 | $0.00 | 5,318.0000 | 70,633,023 | 25.00% | 0.00% |
| April 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Common Share | 521 | $19.70 | 124,099.0000 | 70,633,023 | 0.42% | 0.00% |
| April 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Common Share | 1773 | $0.00 | 124,620.0000 | 70,633,023 | 1.44% | 0.00% |
| March 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Share Option | 656 | $0.00 | 56,017.0000 | 71,922,915 | 1.16% | 0.00% |
| March 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Common Share | 656 | $1.59 | 124,036.0000 | 71,922,915 | 0.53% | 0.00% |
| March 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | S | Class A Common Share | 1189 | $22.03 | 122,847.0000 | 71,922,915 | 0.96% | 0.00% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Common Share | 2727 | $0.00 | 122,794.0000 | 71,634,729 | 2.27% | 0.00% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Common Share | 801 | $17.76 | 121,993.0000 | 71,634,729 | 0.65% | 0.00% |
| Sept. 2, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Common Share | 1964 | $0.00 | 123,957.0000 | 71,634,729 | 1.61% | 0.00% |
| Sept. 2, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Common Share | 577 | $17.76 | 123,380.0000 | 71,634,729 | 0.47% | 0.00% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 2727 | $0.00 | 8,178.0000 | 71,634,729 | 25.01% | 0.00% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Restricted Share Unit | 7091 | $0.00 | 7,091.0000 | 71,634,729 | 9999.99% | 0.01% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Share Option | 42544 | $0.00 | 42,544.0000 | 71,634,729 | 9999.99% | 0.06% |
| Sept. 2, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 1964 | $0.00 | 3,928.0000 | 71,634,729 | 33.33% | 0.00% |
| April 10, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 2727 | $0.00 | 8,178.0000 | 69,751,697 | 50.03% | 0.00% |
| April 10, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Common Share | 801 | $10.71 | 120,067.0000 | 69,751,697 | 0.66% | 0.00% |
| April 10, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Common Share | 2727 | $0.00 | 120,868.0000 | 69,751,697 | 2.31% | 0.00% |
| April 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Restricted Share Unit | 7091 | $0.00 | 7,091.0000 | 69,751,697 | 9999.99% | 0.01% |
| April 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | A | Share Option | 42544 | $0.00 | 42,544.0000 | 69,751,697 | 9999.99% | 0.06% |
| March 20, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 2982 | $0.00 | 0.0000 | 70,421,322 | 100.00% | 0.00% |
| March 16, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Common Share | 1964 | $0.00 | 116,612.0000 | 70,421,322 | 1.71% | 0.00% |
| March 16, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 1964 | $0.00 | 3,928.0000 | 70,421,322 | 33.33% | 0.00% |
| March 20, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Common Share | 876 | $11.12 | 118,141.0000 | 70,421,322 | 0.74% | 0.00% |
| March 20, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | M | Class A Common Share | 2982 | $0.00 | 119,017.0000 | 70,421,322 | 2.57% | 0.00% |
| March 16, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Tessari Eben | CHIEF OPERATING OFFICER | F | Class A Common Share | 577 | $11.46 | 116,035.0000 | 70,421,322 | 0.49% | 0.00% |